TD Asset Management’s MacroGenics MGNX Stock Holding History

TD Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-43,400	Closed	-$141K	–	1246
2024 Q4	$141K	Sell	43,400 -125,600	-74%	-$452K	﹤0.01%	1234
2024 Q3	$539K	Hold	169,000	–	–	﹤0.01%	1292
2024 Q2	$718K	Sell	169,000 -44,448	-21%	-$433K	﹤0.01%	1219
2024 Q1	$3.14M	Buy	213,448 +138,400	+184%	+$2.09M	﹤0.01%	890
2023 Q4	$722K	Buy	75,048 +10,200	+16%	+$70.5K	﹤0.01%	1244
2023 Q3	$302K	Hold	64,848	–	–	﹤0.01%	1337
2023 Q2	$347K	Buy	+64,848	New	+$400K	﹤0.01%	1318
2019 Q2	–	Sell	-11,304	Closed	-$203K	–	1349
2019 Q1	$203K	Sell	11,304 -33,924	-75%	-$586K	﹤0.01%	1308
2018 Q4	$574K	Sell	45,228 -311	-0.7%	-$5.22K	﹤0.01%	1191
2018 Q3	$976K	Buy	45,539 +2,400	+6%	+$51.2K	﹤0.01%	1170
2018 Q2	$891K	Sell	43,139 -200	-0.5%	-$4.5K	﹤0.01%	1156
2018 Q1	$1.09M	Buy	+43,339	New	+$1.05M	﹤0.01%	1040

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TD Asset Management's MGNX Position: Q1 2025 in Review

TD Asset Management sold out of MacroGenics (MGNX) in Q1 2025, closing a stake of 43,400 shares — an estimated $141K sold.

TD Asset Management first reported a position in MGNX in Q1 2018 and held it in 12 quarters. The position peaked at $3.14M in Q1 2024. 128 funds tracked by Wall St. Rank hold MGNX as of Q1 2025.

TD Asset Management reported no remaining MacroGenics position as of Q1 2025 after selling out during the quarter.
TD Asset Management sold 43,400 MacroGenics shares in Q1 2025, an estimated $141K.
TD Asset Management first reported a position in MacroGenics in Q1 2018 and held it in 12 quarters.
TD Asset Management's MacroGenics position peaked at $3.14M in Q1 2024.
128 funds tracked by Wall St. Rank held MacroGenics as of Q1 2025.

Based on TD Asset Management's 13F filing for Q1 2025, filed 7 May 2025.